spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Scientists Protest Trump’s $12 Billion Budget Cuts to NIH

More than 60 scientists and staff members at the U.S. National Institutes of Health (NIH) have issued a rare open letter, strongly criticizing the Trump administration’s sweeping budget cuts. According to the letter, these reductions jeopardize public health, politicize scientific research, and waste public resources.

The letter, addressed to the NIH Director, the U.S. Secretary of Health, and members of Congress, was released ahead of a key Senate Appropriations Committee hearing on the NIH budget.

In total, over 340 current and former NIH employees signed the letter — with approximately 250 requesting anonymity.

The letter outlines that since Trump took office, more than 2,100 research projects worth $9.5 billion have been canceled, along with contracts totaling $2.6 billion. These canceled initiatives were said to be critical for supporting scientific progress — from funding lab equipment to staffing clinical trials.

Hot this week

branding

I Believe in the Improvement of Iran’s Pharmaceutical Landscape

A Conversation with Engineer Seyed Ahmad Mousavi, CEO of...

A Special Interview with Dr. Mohammad Ahmadi, CEO of Pars Darou

A Special Interview with Dr. Mohammad Ahmadi, CEO of...

Our Strategy Is Our Quality

A Special Interview with Dr. Mohammad Taha Dehghan CEO of...

An Exclusive Interview with Dr. Seyed Mehdi Mousavi

A Conversation with Dr. Seyed Mehdi Mousavi — Former...

Topics

I Believe in the Improvement of Iran’s Pharmaceutical Landscape

A Conversation with Engineer Seyed Ahmad Mousavi, CEO of...

A Special Interview with Dr. Mohammad Ahmadi, CEO of Pars Darou

A Special Interview with Dr. Mohammad Ahmadi, CEO of...

Our Strategy Is Our Quality

A Special Interview with Dr. Mohammad Taha Dehghan CEO of...

An Exclusive Interview with Dr. Seyed Mehdi Mousavi

A Conversation with Dr. Seyed Mehdi Mousavi — Former...

Annual Assembly Season for Iran’s Leading Pharmaceutical Companies

The following Ordinary and Extraordinary General Meetings have been...

“The Drug Exists — But Not on the List!”

IRNA Reports on the Complex Realities of Iran’s Pharmaceutical...
spot_img

Related Articles

Popular Categories

spot_imgspot_img